About
Chaim Haber, MD is an internal-medicine physician at the Sheba Longevity Center. Public records connect him to a University of Liverpool MBChB, internal-medicine board certification, and an attending-physician role at Sheba beginning in July 2024. His current work sits close to the center's research engine: patient recruitment and treatment for the SHARP study, ARDD2025 work comparing SECA bioelectrical impedance with DEXA, and co-authored papers with Evelyne Bischof, MD PhD on artificial intelligence in longevity-medicine workflows.
What to Know
Signature approach
Haber brings internal-medicine grounding to Sheba's 12-station assessment and research pathway. His visible work is especially tied to SHARP study operations, body-composition measurement, and AI tools that could make longevity care more consistent across patients and clinicians.
What sets them apart
- Internal medicine plus research operations. His role combines clinical care with SHARP study recruitment and treatment.
- AI-in-longevity publications. Recent co-authored work focuses on implementing artificial intelligence in longevity medicine.
- Body-composition methods. ARDD2025 work compares SECA bioelectrical impedance and DEXA, a useful lens for frailty and muscle-health assessment.
Before You Book
- Team-based visit. Ask during intake which physician is assigned to your assessment if seeing a specific doctor matters.
- Research pathway. If SHARP study participation is relevant, ask how it differs from the standard 360 Diagnostic Process.
- Language. English and Hebrew are supported by his training and work context; confirm any language needs with Sheba.
Expertise
Focus areas
Patient types
Credentials
Education
MBChB, Medicine
University of Liverpool
Board certifications
Internal Medicine
Israeli Medical Association
Board certification in internal medicine — diagnosis and treatment of adult medical conditions across organ systems.
Affiliations
Thought Leadership
Publications
- Implementation of artificial intelligence in the clinical management of longevity · Geromedicine, 2025
- The Role of Machine Learning and Artificial Intelligence in Drug Discovery (Heart Failure Clinics) · Heart Failure Clinics, 2026
Media Appearances
- ARDD2025 conference presentation: Comparison of SECA Bioelectrical Impedance Analysis and DEXA · 12th Aging Research & Drug Discovery (ARDD) Meeting, Copenhagen
Notable Collaborators
- Evelyne Bischof, MD · Co-author on AI-in-longevity-medicine publications and medical director of the Sheba Longevity Center
- Niklas Lidstromer, MD · Karolinska Institutet co-author on both surfaced publications, including the Heart Failure Clinics AI paper
- Dominika Wilczok · University of Copenhagen co-author on the Geromedicine 2026 paper on AI implementation in clinical longevity
Other specialists at Sheba Longevity Center
Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.